An update on that trial: https://www.bmj.com/content/386/bmj.q1706

It doesn't look great.

Absolutely right! This test is hyped. It has abysmally low sensitivity of 16% to detect stage I cancers and overall 44% for cancers of other stages. It is extremely poor sensitivity for any detection test.